Novo Nordisk Obesity Drug Wins FDA Panel Support

An FDA advisory panel recently recommended the approval of Novo Nordisk’s injectable drug liraglutide for the treatment of obesity.

http://www.highlighthealth.com/future-medicine/novo-nordisk-obesity-drug-wins-fda-panel-support/

Advertisements
Tagged , , , , , , , , , , , , , , , ,
%d bloggers like this: